Details for 2013701484
Up to date per 11.05.2026
Actions
Details for 2013701484
Granted/Registered
European Patent
10.12.2014 A
04.10.2017 B1
01.02.2012
US
201261593541 P
A61K 39/00 20060101AFI20130821BHEP
Owner
GlaxoSmithKline Biologicals S.A.Rue de l'Institut, 89 1330 RixensartBE
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
DEHOTTAY, Philippe Marc HeleneGlaxoSmithKline Biologicals s.a. rue de l'Institut 89 1330 RixensartBE
GOFFIN, PhilippeGlaxoSmithKline Biologicals s.a. rue de l'Institut 89 1330 RixensartBE
Information about Fees